Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Nephrology | Urology | Family Medicine
Disease Category: Prostate Cancer
Location: United States, IL

Clinical Trial Details

Overview

Research Study Summary

A Randomized, Double-Blind, Phase 3 Trial Comparing Ipilimumab vs. Placebo Following Radiotherapy in Subjects with Castration Resistant Prostate Cancer That Have Received Prior Treatment with Docetaxel.

Purpose

The purpose of this study is to examine the safety and effectiveness (how well the drug works) of treatment with radiotherapy followed by an investigational compound (a drug that is not currently approved by the United States Food and Drug Administration [FDA] or any other health authority), ipilimumab (also known as MDS-010 or BMS-734016). The effectiveness of ipilimumab will be determined by looking at:

  1. How many patients respond to treatment with radiotherapy followed by ipilimumab versus radiotherapy alone and how long the response lasts for each of these two treatments
  2. Survival time of the patients who receive radiotherapy followed by ipilimumab versus radiotherapy alone
  3. How safe radiotherapy followed by ipilimumab is, and what the side effects are
  4. How much a patient's level of pain changes when treated with radiotherapy followed by ipilimumab versus radiotherapy alone
  5. The health-related quality of life patients experience while on radiotherapy followed by ipilimumab versus radiotherapy alone

Please contact Alexian Brothers for more information on participation.

To Learn more
Phase

3

Gender

Male

Age

N/A

Overall Status

Recruiting

Facility Type

N/A

Contact

Alexian Brothers Hospital Network
800 Biesterfield Road
Elk Grove Village, IL 60007
Phone: 847-952-7164

View Map

Research Center Information: Alexian Brothers Hospital Network

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 176857

Date Last Changed: July 22, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.